International Journal of Nanomedicine · 2020 · 12 citations · 18 references
PharmacyOncologyPharmacologyChemotherapyDrug DeliveryNanoparticle Drug DeliveryCancer Drug DeliveryCancer NanomedicineLipid-based Drug Delivery SystemsLipid-based NanoparticlesNanocarriers For TherapeuticsNanomedicineChemotherapy DeliveryDrug Delivery NanocarriersLipid-based Nanoparticle FormulationNanoparticle-based ChemotherapyNanoparticle-based Macrophage TargetingTumor PenetrationTumor Penetration Of DrugsTumor-targeted Drug Delivery
BACKGROUND: Chemotherapy is the primary treatment for most cancers apart from surgery. However, the use of chemotherapeutic drugs is limited by side effects and restricted accumulation in tumors because of unique tumor microenvironments. Macrophages have excellent drug delivery potential owing to their chemotaxis and can home in on tumors. MATERIALS AND METHODS: We developed an effective drug-delivery system for doxorubicin using macrophages. Doxorubicin-loaded egg yolk lipid-derived nanovectors (EYLNs-Dox) were prepared, EYLNs-Dox-loaded macrophages (Mac/EYLNs-Dox) were developed and their tumor penetration and anti-cancer activity against 4T1 cells were analyzed. The biodistribution and anti-4T1 breast cancer activities were determined using 4T1 subcutaneous and lung metastasis models. RESULTS: EYLNs-Dox was successfully internalized into macrophages without affecting their viability and was less toxic than Dox. Mac/EYLNs-Dox penetrated the 4T1 tumor spheroids more efficiently and was more effective in inhibiting tumors in vitro. Macrophages significantly enhanced the distribution of EYLNs vectors in both inflammatory and tumor sites, playing a more effective role in the inhibition of tumors. CONCLUSION: EYLNs-Dox can be effectively delivered using macrophages and Mac/EYLNs-Dox might be a promising targeted delivery system for breast cancer.
18
Rebecca L. Siegel, Kimberly D. Miller, Ahmedin Jemal · CA A Cancer Journal for Clinicians · 2018 · 17K citations · Full text
Cancer‐Cell‐Biomimetic Nanoparticles for Targeted Therapy of Homotypic Tumors
Huiping Sun, Jinghan Su, Qingshuo Meng et al. · Advanced Materials · 2016 · 647 citations
A Cellular Trojan Horse for Delivery of Therapeutic Nanoparticles into Tumors
Mi-Ran Choi, Katie J. Stanton-Maxey, Jennifer K. Stanley et al. · Nano Letters · 2007 · 584 citations
Tuning payload delivery in tumour cylindroids using gold nanoparticles
Byoung‐Jin Kim, Gang Han, Bhushan J. Toley et al. · Nature Nanotechnology · 2010 · 479 citations · Full text
Pharmacy, Oncology, Pharmaceutics +16